These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 33952237)

  • 1. Tauroursodeoxycholic acid alleviates pulmonary endoplasmic reticulum stress and epithelial-mesenchymal transition in bleomycin-induced lung fibrosis.
    Tong B; Fu L; Hu B; Zhang ZC; Tan ZX; Li SR; Chen YH; Zhang C; Wang H; Xu DX; Zhao H
    BMC Pulm Med; 2021 May; 21(1):149. PubMed ID: 33952237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenylbutyric acid inhibits epithelial-mesenchymal transition during bleomycin-induced lung fibrosis.
    Zhao H; Qin HY; Cao LF; Chen YH; Tan ZX; Zhang C; Xu DX
    Toxicol Lett; 2015 Jan; 232(1):213-20. PubMed ID: 25455454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The exacerbating roles of CCAAT/enhancer-binding protein homologous protein (CHOP) in the development of bleomycin-induced pulmonary fibrosis and the preventive effects of tauroursodeoxycholic acid (TUDCA) against pulmonary fibrosis in mice.
    Tanaka Y; Ishitsuka Y; Hayasaka M; Yamada Y; Miyata K; Endo M; Kondo Y; Moriuchi H; Irikura M; Tanaka K; Mizushima T; Oike Y; Irie T
    Pharmacol Res; 2015 Sep; 99():52-62. PubMed ID: 26005208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin inhibits endoplasmic reticulum stress and epithelial-mesenchymal transition during bleomycin-induced pulmonary fibrosis in mice.
    Zhao H; Wu QQ; Cao LF; Qing HY; Zhang C; Chen YH; Wang H; Liu RY; Xu DX
    PLoS One; 2014; 9(5):e97266. PubMed ID: 24818755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways.
    Ma WH; Li M; Ma HF; Li W; Liu L; Yin Y; Zhou XM; Hou G
    Life Sci; 2020 Jan; 241():117139. PubMed ID: 31809714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mushroom Inonotus sanghuang alleviates experimental pulmonary fibrosis: Implications for therapy of pulmonary fibrosis.
    Su X; Liu K; Xie Y; Zhang M; Wu X; Zhang Y; Wang J
    Biomed Pharmacother; 2021 Jan; 133():110919. PubMed ID: 33202282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D deficiency exacerbates bleomycin-induced pulmonary fibrosis partially through aggravating TGF-β/Smad2/3-mediated epithelial-mesenchymal transition.
    Li SR; Tan ZX; Chen YH; Hu B; Zhang C; Wang H; Zhao H; Xu DX
    Respir Res; 2019 Nov; 20(1):266. PubMed ID: 31775746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.
    Gao L; Jiang D; Geng J; Dong R; Dai H
    Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
    Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
    BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
    Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
    Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitriol inhibits bleomycin-induced early pulmonary inflammatory response and epithelial-mesenchymal transition in mice.
    Tan ZX; Chen YH; Xu S; Qin HY; Zhang C; Zhao H; Xu DX
    Toxicol Lett; 2016 Jan; 240(1):161-71. PubMed ID: 26520185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dasatinib Suppresses TGFβ-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis.
    Kanemaru R; Takahashi F; Kato M; Mitsuishi Y; Tajima K; Ihara H; Hidayat M; Wirawan A; Koinuma Y; Hayakawa D; Yagishita S; Ko R; Sato T; Harada N; Kodama Y; Nurwidya F; Sasaki S; Niwa SI; Takahashi K
    Lung; 2018 Oct; 196(5):531-541. PubMed ID: 29926178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of intermittent hypoxia-induced apoptosis and fibrosis in pulmonary tissues via suppression of ER stress activation.
    Shi Z; Xu L; Xie H; Ouyang R; Ke Y; Zhou R; Yung WH
    BMC Pulm Med; 2020 Apr; 20(1):92. PubMed ID: 32299413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isorhamnetin protects against bleomycin-induced pulmonary fibrosis by inhibiting endoplasmic reticulum stress and epithelial-mesenchymal transition.
    Zheng Q; Tong M; Ou B; Liu C; Hu C; Yang Y
    Int J Mol Med; 2019 Jan; 43(1):117-126. PubMed ID: 30387812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17A contributes to HSV1 infection-induced acute lung injury in a mouse model of pulmonary fibrosis.
    Chen T; Qiu H; Zhao MM; Chen SS; Wu Q; Zhou NY; Lu LQ; Song JC; Tang DL; Weng D; Li HP
    J Cell Mol Med; 2019 Feb; 23(2):908-919. PubMed ID: 30378252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung.
    Lucattelli M; Fineschi S; Selvi E; Garcia Gonzalez E; Bartalesi B; De Cunto G; Lorenzini S; Galeazzi M; Lungarella G
    Respir Res; 2016 May; 17(1):49. PubMed ID: 27153807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probucol ameliorates EMT and lung fibrosis through restoration of SIRT3 expression.
    Zhang HX; Li YN; Wang XL; Ye CL; Zhu XY; Li HP; Yang T; Liu YJ
    Pulm Pharmacol Ther; 2019 Aug; 57():101803. PubMed ID: 31085231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise training ameliorates bleomycin-induced epithelial mesenchymal transition and lung fibrosis through restoration of H
    Du SF; Wang XL; Ye CL; He ZJ; Li DX; Du BR; Liu YJ; Zhu XY
    Acta Physiol (Oxf); 2019 Feb; 225(2):e13177. PubMed ID: 30136377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
    Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
    J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of PIM1 kinase attenuates bleomycin-induced pulmonary fibrosis in mice by modulating the ZEB1/E-cadherin pathway in alveolar epithelial cells.
    Zhang X; Zou Y; Liu Y; Cao Y; Zhu J; Zhang J; Chen X; Zhang R; Li J
    Mol Immunol; 2020 Sep; 125():15-22. PubMed ID: 32619930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.